Bio-Rad Laboratories, Inc. (BIO) vs Oscar Health, Inc. (OSCR)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 5, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnBIO vs OSCR

growth of $100 · dividends reinvested · last 5y
BIO -44.0%OSCR -11.7%OSCR compounded faster
050100Start $10020222023202420252026$56$88
BIO OSCR

BIO vs OSCR: by the numbers

  • BIO is the larger company ($9.36B vs $7.81B market cap).
  • BIO is profitable (8.59% net margin) while OSCR runs a net loss (-0.30%).
  • OSCR grew revenue faster over the past five years (73.14% vs 0.29% CAGR).

Metrics side by side

Valuation

MetricBIOOSCR
P/E ratio40.33N/A
Forward P/E36.7927.29
P/S ratio3.450.75
P/B ratio1.245.97
EV / EBITDA25.20139.61
FCF yield3.96%28.17%

Profitability

MetricBIOOSCR
Gross margin51.90%17.39%
Operating margin9.08%0.08%
Net margin8.59%-0.30%
ROE3.10%-2.37%
ROIC2.04%-27.10%

Growth (annualized)

MetricBIOOSCR
Revenue CAGR (5Y)0.29%73.14%
EPS CAGR (5Y)-26.27%N/A
FCF CAGR (5Y)-9.65%46.32%
Total return CAGR (5Y)-15.28%14.06%

Frequently asked

Which has grown faster, BIO or OSCR?
Over the past five years, OSCR grew revenue faster — BIO at a 0.29% CAGR versus OSCR at 73.14%.
Is BIO or OSCR more profitable?
BIO runs the higher net margin — BIO at 8.59% versus OSCR at -0.30%.
How have BIO and OSCR total returns compared?
Over the past 5 years, BIO delivered 7.94% and OSCR delivered 14.06% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 5, 2026.